For non EU samples how do you cope with Nagoya Protocol obligations on access to genetic resources? Are they a barrier?

They are an important consideration in many projects and one of the reasons that we have begun to form partnerships with in-country labs in many cases where we have opportunities for large projects in non-EU countries. Every country implements the Nagoya protocol in a different way so some places are easier to work in than others and we have to take it on a case-by-case basis. We invest in building up strong networks of governmental and non-governmental stakeholders in the regions where we work, and supporting the development of key resources such as national reference libraries.